The authors declare that they have no competing interests.
EVP and LMC conceived of the study, and participated in its design and coordination and helped to draft the manuscript. FS participated in the design of the study and helped with the images’ adquisition. All authors read and approved the final manuscript.
Central serous chorioretinopathy is a disorder often related to systemic corticosteroids, drugs commonly used in rheumatologists’ clinical practice. Central serous chorioretinopathy prognosis is generally good but in some cases, it may lead to substantial loss of vision resulting in an important functional limitation for patients.
It is very important to distinguish this pathology from other diseases involving retinal detachment. When central serous chorioretinopathy and uveitis coexist, it is mandatory to distinguish serous retinal detachment from a uveitis worsening, as the respective treatments can be radically different.
We describe three cases of central serous chorioretinopathy in patients taking systemic corticosteroids due to rheumatological diseases (ankylosing spondylitis, systemic lupus erythematosus and Behçet’s disease). They were diagnosed and managed at our Multidisciplinary (Rheumatology-Ophthalmology) Uveitis Clinic. All three cases improved after corticosteroids dose tapering.
Central serous chorioretinopathy must be kept in mind by rheumatologists as it is related to systemic corticosteroids.
Hannouche D1, Korobelnik JF, Cochereau I, Hayem G, Beaudreuil J, Meyer O, et al. Systemic lupus erythematosus with choroidopathy and serous retinal detachment. Int Ophtalmol. 1995;19(2):125–7.
Matsuo T, Nakayama T, Koyama T, Matsuo N. Multifocal pigment epitelial damages with serous retinal detachment in systemic lupus erythematosus. Ophtalmologica. 1987;195(2):97–102. CrossRef
- Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases
Elia Valls Pascual
- BioMed Central
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II